{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:32:00Z","timestamp":1744716720124},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1996,6,1]],"date-time":"1996-06-01T00:00:00Z","timestamp":833587200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1996,6]]},"DOI":"10.1007\/bf01271233","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T00:05:11Z","timestamp":1111622711000},"page":"737-748","source":"Crossref","is-referenced-by-count":7,"title":["Motor actions of eliprodil in the normal and monoamine-depleted mouse: A role in the treatment of Parkinson's disease?"],"prefix":"10.1007","volume":"103","author":[{"given":"S.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. S.","family":"Starr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"Starr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","volume":"12","author":"RL Albin","year":"1989","unstructured":"Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12: 366?375","journal-title":"Trends Neurosci"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0306-4522(92)90006-N","volume":"46","author":"RL Albin","year":"1992","unstructured":"Albin RL, Makowiec RL, Hollingsworth ZR, Dure LS, Penney JB, Young AB (1992) Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience 46: 35?48","journal-title":"Neuroscience"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.2402638","volume":"249","author":"H Bergman","year":"1990","unstructured":"Bergman H, Wichman T, DeLong MR (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249: 1436?1438","journal-title":"Science"},{"key":"CR4","doi-asserted-by":"crossref","unstructured":"Biggs CS, Fowler LJ, Whitton PS, Starr MS (1996) N-Methyl-D-aspartate antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats. Eur J Pharmacol (in press)","DOI":"10.1016\/0014-2999(95)00837-3"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0140-6736(92)92466-S","volume":"340","author":"U Bonuccelli","year":"1992","unstructured":"Bonuccelli U, Del Dotto P, Piccini P, Behg\u00e9 F, Corsini GU, Muratorio A (1992) D extremethorphan and parkinsonism. Lancet 340: 53","journal-title":"Lancet"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01244978","volume":"94","author":"ML Carlsson","year":"1993","unstructured":"Carlsson ML (1993) Are the disparate pharmacological profiles of competitive and uncompetitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? J Neural Transm [Gen Sect] 94: 1?10","journal-title":"J Neural Transm [Gen Sect]"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF01258633","volume":"75","author":"M Carlsson","year":"1989","unstructured":"Carlsson M, Carlsson A (1989) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75: 221?226","journal-title":"J Neural Transm"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02246054","volume":"119","author":"CB Carroll","year":"1995","unstructured":"Carroll CB, Holloway V, Brotchie JM, Mitchell IJ (1995) Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptoms. Psychopharmacology 119: 55?65","journal-title":"Psychopharmacology"},{"key":"CR9","first-page":"595","volume":"17","author":"AJ Carter","year":"1992","unstructured":"Carter AJ (1992) Glycine antagonists: regulation of the NMDA receptor-channel complex by the strychnine-insensitive glycine site. Drugs of the Future 17: 595?613","journal-title":"Drugs of the Future"},{"key":"CR10","first-page":"573","volume":"269","author":"AJ Carter","year":"1994","unstructured":"Carter AJ (1994) Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination. J Pharmacol Exp Ther 269: 573?580","journal-title":"J Pharmacol Exp Ther"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1021\/jm00114a018","volume":"34","author":"BL Chenard","year":"1991","unstructured":"Chenard BL, Shalaby IA, Koe BK, Ronau RT, Butler TW, Prochniak MA, Schmidt AW, Fox CW (1991) Separation of ?1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds. J Med Chem 34: 3085?3090","journal-title":"J Med Chem"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF02253435","volume":"7","author":"W Danysz","year":"1994","unstructured":"Danysz W, Gossel M, Zajaczkowski W, Dill D, Quack G (1994) Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats? ? Case of amantadine and memantine. J Neural Transm [P-D Sect] 7: 155?166","journal-title":"J Neural Transm [P-D Sect]"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0091-3057(94)90529-0","volume":"48","author":"G Diana","year":"1994","unstructured":"Diana G, Sagratella S (1994) Different capability of N-methyl-D-aspartate antagonists to affect locomotor\/exploratory activity of mice in a computerized on-line open field test. Pharmacol Biochem Behav 48: 291?295","journal-title":"Pharmacol Biochem Behav"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0166-2236(92)90355-C","volume":"15","author":"CR Gerfen","year":"1992","unstructured":"Gerfen CR (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15: 133?139","journal-title":"Trends Neurosci"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF02244987","volume":"114","author":"MJ Ginski","year":"1994","unstructured":"Ginski MJ, Witkin JM (1994) Sensitive and rapid behavioral differentiation of N-methyl-D-aspartate antagonists. Psychopharmacology 114: 573?582","journal-title":"Psychopharmacology"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-2999(93)90241-9","volume":"236","author":"K Hashimoto","year":"1993","unstructured":"Hashimoto K, London ED (1993) Further characterization of [3H]ifenprodil binding to ? sites in rat brain. Eur J Pharmacol 236: 159?163","journal-title":"Eur J Pharmacol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0014-2999(89)90346-4","volume":"166","author":"M Hiramatsu","year":"1989","unstructured":"Hiramatsu M, Cho AK, Nabeshima T (1989) Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur J Pharmacol 166: 359?366","journal-title":"Eur J Pharmacol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-2999(95)00200-5","volume":"280","author":"S Kaur","year":"1995","unstructured":"Kaur S, Starr MS (1995) Antiparkinsonian action of dextromethorphan in the reserpine-treated mouse. Eur J Pharmacol 280: 159?166","journal-title":"Eur J Pharmacol"},{"key":"CR19","first-page":"969","volume":"245","author":"W Koek","year":"1988","unstructured":"Koek W, Woods J, Winger GD (1988) MK-801, a proposed non-competitive antagonist of excitatory amino acidneurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 245: 969?974","journal-title":"J Pharmacol Exp Ther"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0278-5846(91)90079-G","volume":"15","author":"J Lehmann","year":"1991","unstructured":"Lehmann J, Colpaert F, Canton H (1991) Glutamate and glycine co-activate while polyamines merely modulate the NMDA receptor complex. Progr Neuropsychopharmacol Biol Psychiatry 15: 183?190","journal-title":"Progr Neuropsychopharmacol Biol Psychiatry"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0014-2999(92)90029-4","volume":"215","author":"W L\u00f6scher","year":"1992","unstructured":"L\u00f6scher W, H\u00f6nack D (1992) The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic system. Eur J Pharmacol 215: 199?208","journal-title":"Eur J Pharmacol"},{"key":"CR22","first-page":"492","volume":"6","author":"IL Mitchell","year":"1995","unstructured":"Mitchell IL, Hughes N, Carroll CB, Brotchie JM (1995) Reversal of parkinsonian symptoms by intrastriatal and systemic manipulations of excitatory amino acid and dopamine transmission in the bilateral 6-OHDA lesioned marmoset. Behav Pharmacol 6: 492?507","journal-title":"Behav Pharmacol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/jnnp.55.7.630-a","volume":"85","author":"JL Montastruc","year":"1992","unstructured":"Montastruc JL, Rascol O, Senard JM, Rascol A (1992) A pilot study of NMDA antagonist in Parkinson's disease. J Neurol Neurosurg Psychiatry 85: 630?631","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/mds.870090226","volume":"9","author":"JL Montastruc","year":"1994","unstructured":"Montastruc JL, Fabre N, Rascol O, Senard JM (1994) N-Methyl-D-aspartate (NMDA) antagonist and Parkinson's disease: a pilot study with dextromethorphan. Mov Disord 9: 242?243","journal-title":"Mov Disord"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(93)90969-O","volume":"239","author":"S Murata","year":"1993","unstructured":"Murata S, Kawasaki K (1993) Common and uncommon behavioural effects of antagonists for different modulatory sites in the NMDA receptor\/channel complex. Eur J Pharmacol 239: 9?15","journal-title":"Eur J Pharmacol"},{"key":"CR26","first-page":"A115","volume":"43","author":"R Saenz","year":"1993","unstructured":"Saenz R, Tanner CM, Albers G, Kurth G, Tetrud J (1993) A preliminary study of dextromethorphan as adjunctive therapy in Parkinson's disease. Neurology 43: A115, 15P","journal-title":"Neurology"},{"key":"CR27","first-page":"593","volume":"3","author":"DJ Sanger","year":"1992","unstructured":"Sanger DJ (1992) NMDA antagonists disrupt timing behaviour in rats. Behav Pharmacol 3: 593?600","journal-title":"Behav Pharmacol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1212\/WNL.42.1.255","volume":"42","author":"F Sellai","year":"1992","unstructured":"Sellai F, Hirsch E, Lisovski F, Mutschier V, Collard M, Marescaux C (1992) Contralateral disappearance of parkinsonian signs after subthalamic hematoma. Neurology 42: 255?256","journal-title":"Neurology"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/syn.890190405","volume":"19","author":"MS Starr","year":"1995","unstructured":"Starr MS (1995a) Review: glutamate\/dopamine D1\/D2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse 19: 264?293","journal-title":"Synapse"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF02251229","volume":"10","author":"MS Starr","year":"1995","unstructured":"Starr MS (1995b) Antiparkinsonian actions of glutamate antagonists ? alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms. J Neural Transm [P-D Sect] 10: 141?185","journal-title":"J Neural Transm [P-D Sect]"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF02249338","volume":"114","author":"MS Starr","year":"1994","unstructured":"Starr MS, Starr BS (1994) Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice. Psychopharmacology 114: 469?476","journal-title":"Psychopharmacology"},{"key":"CR32","unstructured":"Starr MS, Starr BS, Kaur S (1995) Stimulation of basal and L-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease. Neurosci Biobehav Rev (in press)"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0014-2999(94)90098-1","volume":"255","author":"C Voltz","year":"1994","unstructured":"Voltz C, Fage D, Carter C (1994) Synergism between the NMDA receptor antagonistic effects of ifenprodil and the glycine site antagonist, 7-chlorokynurenate, in vivo. Eur J Pharmacol 255: 197?202","journal-title":"Eur J Pharmacol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0024-3205(91)90463-L","volume":"48","author":"K Williams","year":"1991","unstructured":"Williams K, Romano C, Dichter MA, Molinoff PB (1991) Minireview: modulation of the NMDA receptor by polyamines. Life Sci 48: 469?498","journal-title":"Life Sci"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0014-2999(92)90414-Y","volume":"210","author":"JJ Woodward","year":"1992","unstructured":"Woodward JJ, Harms J (1992) The putative polyamine antagonists ifenprodil and SL 82.0715 enhance dopamine efflux from rat striatal slices independent of NMDA receptor activation. Eur J Pharmacol 210: 265?270","journal-title":"Eur J Pharmacol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01271233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01271233\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01271233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T14:14:10Z","timestamp":1556633650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01271233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1996,6]]}},"alternative-id":["BF01271233"],"URL":"https:\/\/doi.org\/10.1007\/bf01271233","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,6]]}}}